vimarsana.com

Page 66 - இதழ் ஆஃப் தி அமெரிக்கன் கல்லூரி இருதயவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Low-Risk TAVR at 2 Years: Thrombosis Concerns Creep In

P=0.046) The TAVR group had had more deaths and strokes between 1 and 2 years compared with the SAVR group, according to the PARTNER 3 investigators led by Martin Leon, MD, of Columbia University Irving Medical Center in New York City. Their report was published in the March 9 issue of the Clearly, ongoing assessment of clinical and echocardiographic findings is needed in younger and low-risk patients and planned follow-up in PARTNER 3 will continue through at least 10 years, Leon and colleagues wrote. The convergence in death and stroke came as no surprise to cardiac surgeon Joseph Bavaria, MD, of the Hospital of the University of Pennsylvania in Philadelphia, who participated in the trial.

Short-term Mechanical Circulatory Support: Take the Long View

March 01, 2021 Clinicians caring for patients who require short-term mechanical circulatory support (MCS) should take the long view in order to obtain the best outcomes, a new review asserts. The document, published online today in the Journal of the American College of Cardiology, gathers the literature on what’s known about MCS, particularly the “emerging” Impella (Abiomed) percutaneous left ventricular assist device (LVAD), and explores how these devices are used in cardiogenic shock, right heart failure, and complex coronary interventions. It covers wide ground, as the authors note, “from initial patient selection and access-site management to issues that arise during further intensive care treatment such as hemocompatibility, device positioning, and optimizing hemodynamics.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.